What question did this study set out to answer?

This research aims to identify resistance mechanisms to anti-PD-1 therapy in gastric cancer patients.

CEACAM5/6 and IL-1β Macrophage Mediated Resistance in Gastric Cancer with Anti-PD-1

View Full Paper

Ask AI

Bookmark

This research aims to identify resistance mechanisms to anti-PD-1 therapy in gastric cancer patients.
Single-cell RNA sequencing of 526,583 cells from gastric cancer patients
Analysis of pre- and post-treatment samples
Characterization of resistance pathways related to CEACAM5/6 and IL-1β+ macrophages
CEACAM5/6+ cancer cells predict resistance to anti-PD-1 therapy
IL-1β+ macrophages activate NF-κB pathways leading to chronic inflammation
Increased PD-L1 expression is driven by the inflammatory tumor microenvironment

No takes yet. Share an insight, caveat, or question.

Researchers uncover mechanisms of resistance in gastric cancer, suggesting new targets for immunotherapy.

Zhang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark